New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
11:18 EDTENDP, ACTEndo Health wins appeal ruling over Actavis related to Opana ER
A federal appeals court ruled that a district court erred in concluding that Roxane and Actavis (ACT) had an implied license to practice asserted patents related to Opana ER, which is sold in branded form by Endo Health (ENDP). The appeals court vacated the lower court ruling and remanded the suit for further judgment. Reference Link
News For ENDP;ACT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 20, 2015
08:09 EDTENDPBioSpecifics announces approval of Xiaflex in Japan
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use